Cadrenal Therapeutics, Inc.
Related Filers (8)
- MURPHY JOHN RAYMOND (8)
- Pham Quang X (7)
- Szot Matthew K (3)
- WILSON GLYNN (3)
- LOSORDO DOUGLAS W (3)
- Lisicki Robert (3)
- Zelenkofske Steven (2)
- ARMISTICE CAPITAL, LLC (1)
- Show More ...
Financials (4)
10-Q
Thursday, 11/9/2023
Quarterly Report for period ending 2023-09-30
10-Q
Thursday, 8/10/2023
Quarterly Report for period ending 2023-06-30
10-Q
Wednesday, 5/10/2023
Quarterly Report for period ending 2023-03-31
10-K
Thursday, 3/30/2023
Annual Report for period ending 2022-12-31
News (14)
8-K/A
Thursday, 2/15/2024
Current report filing
8-K
Monday, 2/12/2024
Current report filing
8-K
Thursday, 11/9/2023
Current report filing
8-K
Monday, 10/23/2023
Current report filing
8-K
Friday, 9/8/2023
Current report filing
8-K
Friday, 8/18/2023
Current report filing
8-K
Wednesday, 8/16/2023
Current report filing
8-K
Thursday, 8/10/2023
Current report filing
8-K
Monday, 7/24/2023
Current report filing
8-K
Friday, 7/14/2023
Current report filing
8-K
Friday, 5/26/2023
Current report filing
8-K
Wednesday, 5/10/2023
Current report filing
8-K
Monday, 3/27/2023
Current report filing
8-K
Wednesday, 1/25/2023
Current report filing
Other (16)
ARS
Monday, 8/28/2023
Annual report to security holders
EFFECT
Friday, 7/28/2023
Notice of Effectiveness
CORRESP
Wednesday, 7/26/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Tuesday, 7/18/2023
Exempt (Private) Offering
SEC STAFF LETTER
Friday, 1/20/2023
None
CERT
Friday, 1/20/2023
Certification by an exchange approving securities for listing
EFFECT
Thursday, 1/19/2023
Notice of Effectiveness
CORRESP
Tuesday, 1/17/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 1/17/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
8-A12B
Tuesday, 1/17/2023
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Thursday, 12/8/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Thursday, 12/8/2022
Exempt (Private) Offering
CORRESP
Monday, 10/17/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Wednesday, 10/12/2022
None
CORRESP
Thursday, 9/22/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Monday, 7/25/2022
Exempt (Private) Offering
Ownership (30)
SC 13G
Wednesday, 2/14/2024
ARMISTICE CAPITAL, LLC: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
MURPHY JOHN RAYMOND: Major Shareholders
SC 13G
Monday, 2/12/2024
Pham Quang X: Major Shareholders
4
Monday, 2/12/2024
Pham Quang X: Statement of changes in beneficial ownership of securities
4
Friday, 1/19/2024
MURPHY JOHN RAYMOND: Statement of changes in beneficial ownership of securities
4
Friday, 1/19/2024
Szot Matthew K: Statement of changes in beneficial ownership of securities
4
Friday, 1/19/2024
Pham Quang X: Statement of changes in beneficial ownership of securities
4
Friday, 1/19/2024
WILSON GLYNN: Statement of changes in beneficial ownership of securities
4
Friday, 1/19/2024
Lisicki Robert: Statement of changes in beneficial ownership of securities
4
Friday, 1/19/2024
Zelenkofske Steven: Statement of changes in beneficial ownership of securities
4
Friday, 1/19/2024
LOSORDO DOUGLAS W: Statement of changes in beneficial ownership of securities
4
Friday, 10/6/2023
MURPHY JOHN RAYMOND: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/6/2023
Pham Quang X: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/5/2023
Pham Quang X: Statement of changes in beneficial ownership of securities
3
Monday, 7/24/2023
Lisicki Robert: Initial statement of beneficial ownership of securities
4
Monday, 7/24/2023
Lisicki Robert: Statement of changes in beneficial ownership of securities
3/A
Friday, 3/31/2023
LOSORDO DOUGLAS W: Initial statement of beneficial ownership of securities
SC 13G
Monday, 3/27/2023
MURPHY JOHN RAYMOND: Major Shareholders
4
Wednesday, 3/22/2023
MURPHY JOHN RAYMOND: Statement of changes in beneficial ownership of securities
4
Thursday, 3/16/2023
MURPHY JOHN RAYMOND: Statement of changes in beneficial ownership of securities
4
Monday, 2/13/2023
Pham Quang X: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/24/2023
WILSON GLYNN: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/24/2023
MURPHY JOHN RAYMOND: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/24/2023
Szot Matthew K: Statement of changes in beneficial ownership of securities
3
Thursday, 1/19/2023
LOSORDO DOUGLAS W: Initial statement of beneficial ownership of securities
3
Thursday, 1/19/2023
Zelenkofske Steven: Initial statement of beneficial ownership of securities
3
Thursday, 1/19/2023
Szot Matthew K: Initial statement of beneficial ownership of securities
3
Thursday, 1/19/2023
Pham Quang X: Initial statement of beneficial ownership of securities
3
Thursday, 1/19/2023
MURPHY JOHN RAYMOND: Initial statement of beneficial ownership of securities
3
Thursday, 1/19/2023
WILSON GLYNN: Initial statement of beneficial ownership of securities
Prospectus (18)
424B3
Wednesday, 8/16/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Tuesday, 8/1/2023
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Monday, 7/24/2023
General form of registration statement for all companies including face-amount certificate companies
S-8
Tuesday, 1/24/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Monday, 1/23/2023
Prospectus filed pursuant to Rule 424(b)(4)
424B4
Monday, 1/23/2023
Prospectus filed pursuant to Rule 424(b)(4)
S-1/A
Tuesday, 1/17/2023
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Wednesday, 12/28/2022
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Thursday, 12/8/2022
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Tuesday, 12/6/2022
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Monday, 10/17/2022
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Tuesday, 10/11/2022
General form of registration statement for all companies including face-amount certificate companies
S-1
Thursday, 9/22/2022
General form of registration statement for all companies including face-amount certificate companies
DRSLTR
Friday, 9/2/2022
Correspondence Related to Draft Registration Statement
DRS/A
Friday, 9/2/2022
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Tuesday, 8/23/2022
Correspondence Related to Draft Registration Statement
DRS/A
Tuesday, 8/23/2022
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Friday, 7/15/2022
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (3)
DEFA14A
Thursday, 8/31/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Thursday, 8/31/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Monday, 8/28/2023
Definitive proxy statements